Increased Incidence of Epilepsy in a Brain Bank Alzheimer's Disease Cohort and Its Association With TDP‐43 Pathology
Neuropathology and Applied Neurobiology · 2025
DOI: 10.1111/nan.70034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuropathology and Applied Neurobiology, 2025. Verfasst von Federica Rocca und 7 weiteren Autor:innen. Beteiligte Einrichtung: London Neurodegenerative Diseases Brain Bank, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology & Neuroscience, King…. Hauptthemen laut MEDLINE: Alzheimer Disease, DNA-Binding Proteins, Epilepsy, Brain. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Brains for Dementia Research, Alzheimer's Society, Alzheimer's Research UK.
Themen: Demenz
Abstract (Originalsprache)
Aims
Evidence suggests Alzheimer's disease ( AD ) patients are at increased risk of epilepsy and that seizure incidence is associated with faster cognitive decline. Previous studies indicate hyperphosphorylated tau may play a role in this disease association; however, abnormal TDP‐43 and α‐synuclein deposition have not been extensively examined.
Methods
Clinical and neuropathological records of AD cases over a 5‐year period were retrieved from the London Neurodegenerative Diseases Brain Bank. The 114 cases were categorised into three groups: AD plus epilepsy, AD plus hippocampal sclerosis (HS) and AD only. Semi‐quantitative scores for tau, TDP‐43 and α‐synuclein pathology within the middle temporal gyrus, hippocampus and amygdala were compared between groups.
Results
A 12% incidence of epilepsy and/or epileptic symptomology was found among the cohort. Twelve cases (11%) showed HS. No significant difference in tau pathology scores was seen between groups. However, a significantly higher score for TDP‐43 was seen in AD plus epilepsy compared with AD only in the middle temporal gyrus ( p = 0.004). The burden of α‐synuclein pathology was increased in the amygdala of AD plus epilepsy and AD plus HS.
Conclusions
The incidence of epilepsy within this AD cohort is higher than expected within the general population (even when matched for age), and this may be associated with increased TDP‐43 burden. Understanding the relationship between AD and epilepsy may highlight mechanisms of cellular damage and tissue vulnerability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- London Neurodegenerative Diseases Brain Bank, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
- Department of Clinical Neuropathology, King's College Hospital NHS Trust, London, UK.
ORCID-Profile: Federica Rocca, Safa Al-Sarraj
Förderung
- Brains for Dementia Research
- Alzheimer's Society
- Alzheimer's Research UK
Zitieren
APA
Rocca, F., Kennedy, J., Osman, S., Reisz, Z., King, A., Bodi, I., Al-Sarraj, S., & Troakes, C. (2025). Increased Incidence of Epilepsy in a Brain Bank Alzheimer's Disease Cohort and Its Association With TDP‐43 Pathology. Neuropathology and Applied Neurobiology. https://doi.org/10.1111/nan.70034
Vancouver
Rocca F, Kennedy J, Osman S, Reisz Z, King A, Bodi I, et al. Increased Incidence of Epilepsy in a Brain Bank Alzheimer's Disease Cohort and Its Association With TDP‐43 Pathology. Neuropathology and Applied Neurobiology. 2025. doi:10.1111/nan.70034
BibTeX
@article{Rocca2025,
author = {Rocca, Federica and Kennedy, Jaimee and Osman, Shamis and Reisz, Zita and King, Andrew and Bodi, Istvan and Al-Sarraj, Safa and Troakes, Claire},
title = {Increased Incidence of Epilepsy in a Brain Bank Alzheimer's Disease Cohort and Its Association With TDP‐43 Pathology},
journal = {Neuropathology and Applied Neurobiology},
year = {2025},
doi = {10.1111/nan.70034}
}
EUVIMED